DEFINITIVE PROXY STATEMENT

Company

Eloxx Pharmaceuticals, Inc.

Filed

October 27, 2000

Period of Report

November 30, 2000

Accession Number

0001015357-00-000184

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →